1. Bailar, J.C., Mellinger, G.T., Gleason, D.F.: Survival rates of patients with prostatic cancer, tumor stage and differentiation–preliminary report. Cancer Chemother. Rep. 50, 129–136 (1966)
2. Blackard, C.E., Byar, D.P., Seal, U.S., Doe, R.P., Veterans Administration Cooperative Urological Research Group: Correlation of pretreatment serum non-protein bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer. New Engl. J. Med. 291, 751–755 (Oct., 1974 )
3. Blackard, J.C., Doe, R.P., Mellinger, G.T., Byar, D.P.: Incidence of cardiovascular disease in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer (Philad.) 26, 249–256 (1970)
4. Blackard, J.C., Byar, D.P., Seal, U.S., Doe, R.P., Veterans Administration Cooperative Urological Research Group: Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancer. J. Urol. (Baltimore) 113, 517–520 (April, 1975 )
5. Byar, D.P.: The Veterans Administration Cooperative Urological Research Group’s studies of cancer of the prostate. Cancer (Philad.) 32, 1126–1130 (1973)